BR100 Decreased By (-1.08%)
BR30 Decreased By (-1.23%)
KSE100 Decreased By (-0.85%)
KSE30 Decreased By (-1.61%)
AGHA 6.11 Decreased By ▼ -0.07 (-1.13%)
BECO 4.12 Decreased By ▼ -0.11 (-2.6%)
BML 61.59 Decreased By ▼ -0.25 (-0.4%)
BOP 30.94 Decreased By ▼ -0.76 (-2.4%)
CNERGY 12.10 Increased By ▲ 0.04 (0.33%)
CSIL 5.65 Increased By ▲ 0.02 (0.36%)
FCCL 58.05 Decreased By ▼ -0.66 (-1.12%)
FFL 13.35 Decreased By ▼ -0.12 (-0.89%)
FNEL 1.16 Decreased By ▼ -0.01 (-0.85%)
KEL 6.11 Decreased By ▼ -0.03 (-0.49%)
KOSM 5.61 Decreased By ▼ -0.05 (-0.88%)
LOTCHEM 24.43 Decreased By ▼ -0.39 (-1.57%)
MLCF 100.04 Decreased By ▼ -2.05 (-2.01%)
NBP 175.92 Decreased By ▼ -3.74 (-2.08%)
NCPL 51.73 Increased By ▲ 1.68 (3.36%)
NPL 53.95 Increased By ▲ 1.05 (1.98%)
OGDC 312.89 Decreased By ▼ -3.35 (-1.06%)
PACE 9.22 Increased By ▲ 0.01 (0.11%)
PAEL 33.48 Decreased By ▼ -0.54 (-1.59%)
PIBTL 13.19 Decreased By ▼ -0.23 (-1.71%)
PPL 217.96 Decreased By ▼ -3.34 (-1.51%)
PRL 85.55 Increased By ▲ 0.95 (1.12%)
PTC 47.64 Decreased By ▼ -0.74 (-1.53%)
SSGC 22.60 Decreased By ▼ -0.34 (-1.48%)
TBL 9.16 Decreased By ▼ -0.14 (-1.51%)
TELE 7.15 Increased By ▲ 0.08 (1.13%)
TPL 25.48 Decreased By ▼ -0.38 (-1.47%)
TPLP 13.36 Increased By ▲ 0.25 (1.91%)
TREET 24.56 Decreased By ▼ -0.43 (-1.72%)
TRG 53.41 Decreased By ▼ -0.62 (-1.15%)
Markets

CBOT soybeans may test support at $14.04-1/2

  • The drop from the March 8 high of $14.60 looks incomplete. It consists of three waves. The second wave labelled b is ending around $14.20-1/2.
Published Updated
By

SINGAPORE: The CBOT soybean May contract may test support at $14.04-1/2 per bushel, a break below which could open the way towards $13.91-1/2.

The drop from the March 8 high of $14.60 looks incomplete. It consists of three waves. The second wave labelled b is ending around $14.20-1/2.

This wave is expected to be reversed by a downward wave c. A break above $14.20-1/2 could lead to a gain into the zone of $14.31-1/2 to $14.46-1/2.

Each reader should consult his or her own professional or other advisers for business, financial or legal advice regarding the products mentioned in the analyses.

Comments

Comments are closed for this article.